Does symptom severity matter in stepped and collaborative care for depression?
• SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Differen...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Watzke, Birgit [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis - Heidari, Somaye-Sadat ELSEVIER, 2021, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:277 ; year:2020 ; day:1 ; month:12 ; pages:287-295 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jad.2020.07.079 |
|---|
| Katalog-ID: |
ELV051630605 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV051630605 | ||
| 003 | DE-627 | ||
| 005 | 20230624175234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jad.2020.07.079 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica |
| 035 | |a (DE-627)ELV051630605 | ||
| 035 | |a (ELSEVIER)S0165-0327(20)32524-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Watzke, Birgit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Does symptom severity matter in stepped and collaborative care for depression? |
| 264 | 1 | |c 2020 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. | ||
| 700 | 1 | |a Heddaeus, Daniela |4 oth | |
| 700 | 1 | |a Steinmann, Maya |4 oth | |
| 700 | 1 | |a Daubmann, Anne |4 oth | |
| 700 | 1 | |a Wegscheider, Karl |4 oth | |
| 700 | 1 | |a Härter, Martin |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Heidari, Somaye-Sadat ELSEVIER |t Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV000041335 |
| 773 | 1 | 8 | |g volume:277 |g year:2020 |g day:1 |g month:12 |g pages:287-295 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jad.2020.07.079 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 277 |j 2020 |b 1 |c 1201 |h 287-295 |g 9 | ||
| author_variant |
b w bw |
|---|---|
| matchkey_str |
watzkebirgitheddaeusdanielasteinmannmaya:2020----:osyposvrtmteisepdnclaoai |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
10.1016/j.jad.2020.07.079 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica (DE-627)ELV051630605 (ELSEVIER)S0165-0327(20)32524-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Watzke, Birgit verfasserin aut Does symptom severity matter in stepped and collaborative care for depression? 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. Heddaeus, Daniela oth Steinmann, Maya oth Daubmann, Anne oth Wegscheider, Karl oth Härter, Martin oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 https://doi.org/10.1016/j.jad.2020.07.079 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 277 2020 1 1201 287-295 9 |
| spelling |
10.1016/j.jad.2020.07.079 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica (DE-627)ELV051630605 (ELSEVIER)S0165-0327(20)32524-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Watzke, Birgit verfasserin aut Does symptom severity matter in stepped and collaborative care for depression? 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. Heddaeus, Daniela oth Steinmann, Maya oth Daubmann, Anne oth Wegscheider, Karl oth Härter, Martin oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 https://doi.org/10.1016/j.jad.2020.07.079 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 277 2020 1 1201 287-295 9 |
| allfields_unstemmed |
10.1016/j.jad.2020.07.079 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica (DE-627)ELV051630605 (ELSEVIER)S0165-0327(20)32524-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Watzke, Birgit verfasserin aut Does symptom severity matter in stepped and collaborative care for depression? 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. Heddaeus, Daniela oth Steinmann, Maya oth Daubmann, Anne oth Wegscheider, Karl oth Härter, Martin oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 https://doi.org/10.1016/j.jad.2020.07.079 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 277 2020 1 1201 287-295 9 |
| allfieldsGer |
10.1016/j.jad.2020.07.079 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica (DE-627)ELV051630605 (ELSEVIER)S0165-0327(20)32524-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Watzke, Birgit verfasserin aut Does symptom severity matter in stepped and collaborative care for depression? 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. Heddaeus, Daniela oth Steinmann, Maya oth Daubmann, Anne oth Wegscheider, Karl oth Härter, Martin oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 https://doi.org/10.1016/j.jad.2020.07.079 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 277 2020 1 1201 287-295 9 |
| allfieldsSound |
10.1016/j.jad.2020.07.079 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica (DE-627)ELV051630605 (ELSEVIER)S0165-0327(20)32524-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Watzke, Birgit verfasserin aut Does symptom severity matter in stepped and collaborative care for depression? 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. Heddaeus, Daniela oth Steinmann, Maya oth Daubmann, Anne oth Wegscheider, Karl oth Härter, Martin oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 https://doi.org/10.1016/j.jad.2020.07.079 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 277 2020 1 1201 287-295 9 |
| language |
English |
| source |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 |
| sourceStr |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:277 year:2020 day:1 month:12 pages:287-295 extent:9 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| authorswithroles_txt_mv |
Watzke, Birgit @@aut@@ Heddaeus, Daniela @@oth@@ Steinmann, Maya @@oth@@ Daubmann, Anne @@oth@@ Wegscheider, Karl @@oth@@ Härter, Martin @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000041335 |
| dewey-sort |
3570 |
| id |
ELV051630605 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV051630605</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624175234.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2020.07.079</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV051630605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(20)32524-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Watzke, Birgit</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Does symptom severity matter in stepped and collaborative care for depression?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heddaeus, Daniela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinmann, Maya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Daubmann, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wegscheider, Karl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Härter, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:277</subfield><subfield code="g">year:2020</subfield><subfield code="g">day:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:287-295</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2020.07.079</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">277</subfield><subfield code="j">2020</subfield><subfield code="b">1</subfield><subfield code="c">1201</subfield><subfield code="h">287-295</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| author |
Watzke, Birgit |
| spellingShingle |
Watzke, Birgit ddc 570 Does symptom severity matter in stepped and collaborative care for depression? |
| authorStr |
Watzke, Birgit |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000041335 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 540 VZ Does symptom severity matter in stepped and collaborative care for depression? |
| topic |
ddc 570 |
| topic_unstemmed |
ddc 570 |
| topic_browse |
ddc 570 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d h dh m s ms a d ad k w kw m h mh |
| hierarchy_parent_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| hierarchy_parent_id |
ELV000041335 |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000041335 |
| title |
Does symptom severity matter in stepped and collaborative care for depression? |
| ctrlnum |
(DE-627)ELV051630605 (ELSEVIER)S0165-0327(20)32524-6 |
| title_full |
Does symptom severity matter in stepped and collaborative care for depression? |
| author_sort |
Watzke, Birgit |
| journal |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| journalStr |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
287 |
| author_browse |
Watzke, Birgit |
| container_volume |
277 |
| physical |
9 |
| class |
570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Watzke, Birgit |
| doi_str_mv |
10.1016/j.jad.2020.07.079 |
| dewey-full |
570 540 |
| title_sort |
does symptom severity matter in stepped and collaborative care for depression? |
| title_auth |
Does symptom severity matter in stepped and collaborative care for depression? |
| abstract |
• SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. |
| abstractGer |
• SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. |
| abstract_unstemmed |
• SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Does symptom severity matter in stepped and collaborative care for depression? |
| url |
https://doi.org/10.1016/j.jad.2020.07.079 |
| remote_bool |
true |
| author2 |
Heddaeus, Daniela Steinmann, Maya Daubmann, Anne Wegscheider, Karl Härter, Martin |
| author2Str |
Heddaeus, Daniela Steinmann, Maya Daubmann, Anne Wegscheider, Karl Härter, Martin |
| ppnlink |
ELV000041335 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.jad.2020.07.079 |
| up_date |
2024-07-06T20:47:31.434Z |
| _version_ |
1803864088441257984 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV051630605</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624175234.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2020.07.079</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001217.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV051630605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(20)32524-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Watzke, Birgit</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Does symptom severity matter in stepped and collaborative care for depression?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• SCM is effective for both mildly to moderately and severely depressed patients. • Effects are higher for mildly to moderately depressed patients. • Special attention must be paid to severely depressed patients. • SCM patients more often received outpatient depression-specific treatment. • Difference in treatment utilization is higher for not severely depressed patients.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heddaeus, Daniela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinmann, Maya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Daubmann, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wegscheider, Karl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Härter, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:277</subfield><subfield code="g">year:2020</subfield><subfield code="g">day:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:287-295</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2020.07.079</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">277</subfield><subfield code="j">2020</subfield><subfield code="b">1</subfield><subfield code="c">1201</subfield><subfield code="h">287-295</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| score |
7.4003296 |